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Abstract
Analysis of somatic mutation profiles from cancer patients is essential in the devel-
opment of cancer research. However, the low frequency of most mutations and the
varying rates of mutations across patients makes the data extremely challenging
to statistically analyze as well as difficult to use in classification problems, for
clustering, visualization or for learning useful information. Thus, the creation
of low dimensional representations of somatic mutation profiles that hold useful
information about the DNA of cancer cells will facilitate the use of such data in
applications that will progress precision medicine. In this paper, we talk about the
open problem of learning from somatic mutations, and present Flatsomatic: a solu-
tion that utilizes variational autoencoders (VAEs) to create latent representations of
somatic profiles. The work done in this paper shows great potential for this method,
with the VAE embeddings performing better than PCA for a clustering task, and
performing equally well to the raw high dimensional data for a classification task.
We believe the methods presented herein can be of great value in future research
and in bringing data-driven models into precision oncology.
1 Introduction
As part of the decision-making process in cancer therapy selection, oncologists stratify patients into
broad clinical groups. At present, the major indicator for stratification is the site of origin of the
primary tumor. However, with the widespread adoption of next generation sequencing technologies,
our reference for stratification is becoming more complex as we are beginning to understand how
each tumor is unique on the genetic level. The outcome of which is an approach dubbed precision
oncology, which involves the process of identifying genomic features driving an individual tumor
and designing a personalized therapeutic strategy in response.
This presents a classification problem that is well suited to supervised machine learning algorithms,
although high complexity, sparisty, varying set sizes, and high dimensionality of genomic data such
as somatic mutations, makes this difficult. Models cannot be applied directly on raw somatic mutation
data, and sub-optimal data transformation of these data into something suitable will yield sub-optimal
performance of the resultant model.
In this paper we discuss the open problem of learning from somatic mutations and we present a
solution, Flatsomatic: a Variational Auto Encoder optimized to compress somatic mutations to allow
for unbiased data compression whilst maintaining signal. We hope the methods presented here can
enable greater use of somatic mutation information in machine learning algorithms.
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2 The Data
Somatic mutation input data for a given patient is a set of mutations {M1, ...,Mn}with n representing
the number of mutations. Somatic mutation data Mi has features including (but not limited to)
chromosome number (chr), position in chromosome (pos), and Variant Allele Frequency (VAF). For
The Cancer Genome Atlas (TCGA)[1] dataset, we observe these features across 8062 patients, with
anywhere between 2 and 1000 mutations from a set of millions of possible mutations.
Our approach to these data is to limit ourselves to positional features only (chromosome number,
position in chromosome) and to reduce the mutations occurring in a given location a same datum by
applying a surjection that concatenates the positional features.
Figure 1: Application of a concatenation function on a subset of features from the initial set (left)
creates a set (right) of lower cardinality
The advantage of this method is a decrease in space to 136000 possible mutations and the creation of
a matrix of mutation occurrences from which it is easy to train:
mutation_occurrences =
O11 . . . O1m... . . . ...
On1 . . . Onm

n : number of samples
m : number of observed mutations
Oij : 1 if mutation j occurs in sample i, 0 otherwise.
Finally, as such data is challenging to statistically analyze and difficult to use in classifica-
tion/clustering/visualisation, the creation of low dimensional representations of somatic mutation
profiles is necessary. These hold useful information about the DNA of cancer cells and will facilitate
the use of such data in downstream analysis.
3 Methods
We apply variational autoencoders (VAEs) [2] to create latent representations of somatic profiles
from the mutation_occurrences matrix. The process of building the VAEs to compress somatic
profiles included implementation and optimization of several different neural network architectures.
Several changes to the loss function of the VAE were explored [3] in order to learn more useful
representations. All models were implemented using the Keras library [4] with TensorFlow backend.
The somatic profiles used to train our models were comprised of the aforementioned 8062 TCGA
pan-cancer patients, and 989 cell lines from the COSMIC cell line project (CCLP). The profiles for
each patient are represented by the mutation position in the genome. To pre-process the data, binary
vectors of equal lengths (all mutation locations) were created for each patient. To reduce the sparsity,
the mutation locations with a frequency of less than 5 were removed. To assess the reconstruction
ability of the VAE, we performed a 5 fold cross-validation and used the micro F1-score that we will
simply refer as F1-score.
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3.1 Multi Layer Perceptron based models
The first architecture explored was a feed-forward network also known as multilayer perceptron
(MLP). A two-layer deep network in the encoder/decoder of the VAE were built with a batch
normalization [5] layer after each layer. Different combinations of the number of units in each layer
were attempted and the effect of changing the size of the latent space was studied. A leaky ReLU [6]
activation was used in the encoder layers, and a regular ReLU was used in the decoder layers except
for the final layer in the decoder which employed a sigmoid function. A dropout layer was added
after the first layer in the encoder/decoder, and L1 regularization was used with each dense layer. We
optimized with RMSprop, and the models were trained with a batch size of 128 for 100 epochs.
3.2 Bi-directional LSTM
The second architecture attempted was a bidirectional LSTM [7] to reduce the significance of the
order of mutations, especially those toward the end of the input sequence. Although the order of
mutations in a somatic profile is not important, we expect the occurrence of certain mutations or
a group of mutations together to hold important information, hence this architecture was deemed
suitable to learn deeper patterns in the data. The number of units in the LSTM was explored (1024,
512, 256, or 128) as well as the size of the latent space (128, 64, 32, or 8).
3.3 Changes in Loss Function of VAE
The loss function of the VAE is comprised of a reconstruction loss and a variational regularization
term. The loss function is essential to help the decoder reconstruct a version of the data from the
embeddings as close as possible to the input data. Binary cross-entropy is frequently used as the
reconstruction loss, however, we devised an F1-score based loss function to use as the reconstruction
loss and compared its performance to binary cross-entropy.
L = Ez∼q[log p(x | z)]−DKL(q(z | x) || p(z))
Recent studies [8] have emphasized the importance of the regularization term in the loss function and
the role it plays in creating useful latent representations. To address this, we explored the use of a
beta-VAE [9].
3.4 Assessment of Representation
To assess the representation created by the VAE, 2-dimensional embeddings were created by the best
VAE and compared to a lower dimension version of the data created using principal component anal-
ysis (PCA) [10]. Kmeans clustering was then applied to both low-dimensional versions, and results
were compared to the known cancer types of each profile using Normalized Mututal Information
(NMI) as a measure. The number of clusters created was 32, matching the number of cancer types in
these data. The embeddings were also used in a given classification task and their performance was
compared to results when the raw data was used in the same task.
4 Results
Initial results show the MLP-VAE provides a better performance than the bidirectional LSTM VAE,
with F1-scores of 20.4%, and 17.1% respectively. Our analysis shows a latent space size of >8 is
required for optimum reconstruction ability of the VAE. Table 1 shows the validation F1, found with
different latent space sizes.
Table 1: The effect of Latent Space Size on VAE reconstruction
Latent Space Size 2 8 32 64 128 265 512
F1-score 15.68 20.55 20.88 20.41 20.50 20.18 20.21
We found that the use of F1-score based loss helps the VAE reconstruct this form of data much better
than the binary cross-entropy loss. To assess this, we measure the cosine similarity. Figure 2 shows
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the performance of the VAE while training with the two losses. We also found that introducing the
regularization term using a warm-up function and increasing its weight with each epoch gives the
best performance.
Figure 2: Comparison of F1-loss (left) and Cross-entropy (right) during training
4.1 Visualization
After performing K-means on the embeddings from the best VAE and the lower dimension of the data
created by PCA, plots with reference to the clusters were created. The NMI for the clusters created in
the VAE embeddings was 21%, and for the version created by PCA it was 11%, showing that the
VAE embeddings are a better representation.
4.2 Use-case
We have used Flatsomatic in a semi-supervised setting to predict drug response from the GDSC
[11] dataset. We show (Table 2) that the performances are similar to the raw data. The advantage
of working with smaller spaces is that it enables the use of other relevant features (either clinical
features or other abstract representations of genomic profiles) for future work.
Table 2: Predicting drug response with somatic profile
Data source Dimensionality Precision Recall F1-score
Mutation occurrences 8298 0.732 0.614 0.667
Flatsomatic embeddings 64 0.721 0.621 0.667
5 An Open Problem
For future work we would like to investigate better ways of encoding the initial set of mutations
through retaining the non-positional features and through not introducing sparsity by creating a
mutation_occurrences matrix. We believe that the pre-processing step that consists in reducing the
data into matrices of mutation occurrence is sub-optimal as non-positional features are discarded and
it is assumed that two mutations at the same position will have the same effect.
We also aim to explore additional methods for encoding such data for machine-learning purposes.
One could, for example, encode additional mutation data with a vector including non-positional
features (Variant Allele Frequency, Impact, Missense Nonsense, Base change, etc) and implement a
model that can utilize such variable length inputs, such as a Recurrent Neural Network.
6 Conclusion
The work done in this paper has shown that there is a great potential for the use of VAEs in creating
utilizable lower dimension representations of somatic profiles. The VAE embeddings performed
better than PCA for a clustering task, and performed equally well to the raw high dimensional data for
a classification task. We believe that this work is an important step in the use of somatic mutation data
for machine learning applications, and will help future researchers in bringing data-driven models
into precision oncology.
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